Posted on October 13, 2016

A team of Irish clinical academics have secured one of seven major awards that have been made across the UK and Ireland by the Wellcome Trust as part of an initiative to increase clinical research capability.  The scheme, which will be known as the Wellcome – HRB Irish Clinical Academic Training Programme, will support the intake of eight postgraduate trainee doctors a year for a five-year period, providing fully integrated clinical and research training up to consultant level.

The award represents an overall investment of almost €13 million with €7.5 million coming from Wellcome and the Health Research Board (HRB) matched with a further combined contribution of €5.5 million from the Health Service Executive and the Health and Social Care Research and Development Office, Northern Ireland, and the partner Universities.  The partner universities involved in the programme include Trinity College Dublin, University College Dublin, NUI Galway, University College Cork, Royal College of Surgeons in Ireland and Queen’s University Belfast.

Lead investigators within each institution include:

  • Professor Michael Gill (Trinity College Dublin, Director & Co-Investigator)
  • Professor Paddy Mallon (University College Dublin, Deputy Director & Co-Investigator)
  • Professor Conall Dennedy (NUI, Galway, Co-investigator)
  • Professor Joe Eustace (University College Cork, Co-investigator)
  • Professor Ray Stallings (Royal College of Surgeons in Ireland, Co-investigator)
  • Professor Peter Maxwell (Queen’s University Belfast, Co-investigator)
  • Dr Mark Watson (Molecular Medicine Ireland, Co-ordinator)

The programme will be open to applications in autumn 2016 for an intake beginning in July 2017 and is being coordinated through Molecular Medicine Ireland, an inter-University collaborative entity owned by NUIG, RCSI, TCD, UCC and UCD.

Announcing the programme today, Minister for Health, Mr Simon Harris TD noted that

A research-active health system is proven to have better outcomes for patients.  Patients will be the long-term winners as this collaborative investment will fundamentally improve both the number and calibre of Clinician Scientists working in our universities and health services.  I’m really pleased to announce this significant investment in the future of the health service, and I know the positive impact for patient care is going to be very real.  I very much look forward to seeing this important programme in action over the next few years.  I welcome the strong collaboration that is core to this research award, and I am particularly pleased that Northern Ireland is part of it, making this an all island and multi-institutional Programme.

Northern Ireland’s Health Minister, Ms Michelle O Neill MLA said;

This is the largest ever investment in academic medicine through an all island collaborative partnership and it will make a real difference to the health of people across the island of Ireland and further afield.  I want to congratulate all those involved in securing this programme and in particular pay tribute to the role played by Professor Peter Maxwell, from Queen’s University in Belfast.   This initiative demonstrates what can be achieved through collaborative working across the whole island of Ireland.

Professor Michael Gill, Principal Investigator and Director of the Wellcome-HRB Irish Clinical Academic Training Programme said,

Our goal in securing this award was to enable a fundamental change in the training of future academic clinicians on an all-Ireland basis. At its core is a fully integrated clinical and research programme that will provide seamless, supported and mentored training of the highest standard, targeting future clinical academic leaders in the universities and health care system.

The programme will identify, recruit, and mentor doctors during their postgraduate training who have the potential to become future academic leaders. They will be supported through a structured career pathway, aligned with our national research strengths and postgraduate specialities. In doing so, this programme will position Ireland well to meet future challenges in clinical innovation and excellence in healthcare.

Our application has the full support of all major stakeholders; the Postgraduate Forum representing specialist training bodies, the Health Services North and South, the Universities and the Health Research Board.  Trainee Clinician Scientists will be based at six major Irish universities in Belfast, Cork, Dublin and Galway, and will be able to take advantage of existing clinical research infrastructures and supports in their associated hospitals, many of which have been funded by the HRB.

Deputy Director of the Programme, Professor Paddy Mallon, Associate Dean for Research, Innovation and Impact at the UCD School of Medicine commented,

This exciting programme represents real systems change in how we train clinician scientists in Ireland and is designed to attract the very best physicians and support them in pursuit of the research excellence. This programme would not have been possible without the investment in national structures for clinical research and training that has been committed over the past decade or more. Funding of this prestigious programme reflects international recognition of the sound infrastructure available within Ireland to conduct the highest quality clinical research.

According to Dr Graham Love, Chief Executive at the Health Research Board,

We are committed to fostering a research-active culture among health professionals so they can continually evolve and improve care.  It is great to see that the ongoing collaboration between the HRB and Wellcome Trust continues to extend new opportunities to researchers in Ireland.

Dr Anne-Marie Coriat, Head of Research Careers at Wellcome said;

This is one of seven new clinical PhD programmes across the UK and Ireland that Wellcome has funded.  Training small groups of PhD students in programmes provides an opportunity to develop cohort focussed training opportunities and further embed clinical academic training within universities and university hospitals.


Brief overview of Programme Structure

Wellcome – HRB Irish Clinical Academic Training

Year 1

Clinical (70%) Academic (30%) Accredited for clinical training. Fellows appointed as Clinical Lecturer and allocated to clinical positions in a university affiliated hospital with protected time to participate in education/research. Three core modules and one elective module will be taken, chosen from an existing Clinician Scientist Curriculum at Molecular Medicine Ireland or from additional modules in any partner institution. Fellows will be supported to make their final choice of supervisor and will submit their research proposal. Progression to PhD will follow independent review of the proposal and interview. With extensive support, we expect low drop-out rates.

Year 2-4

Joint clinical (10%) / Academic (90%). One year accredited for basic or higher specialist training (BST or HST). Continue as Clinical Lecturer. Fellows will complete their research under supervision and will take additional taught components relevant to their PhD. They will maintain limited clinical activity approved by the relevant training body that does not disrupt research.

Year 5-7

Joint clinical (80%) / Academic (20%). Accredited for HST. Continue Clinical Lecturer appointment. Fellows will return to training positions in hospitals aligned with their host university under the guidance of their supervisor and Mentors. Fellows will complete requirements for clinical training while continuing to participate in research, working with their supervisors and mentors to apply for suitable post-doctoral fellowships.

About the Funders


Wellcome exists to improve health for everyone by helping great ideas to thrive. We’re a global charitable foundation, both politically and financially independent. We support scientists and researchers, take on big problems, fuel imaginations and spark debate.

Health Research Board

The Health Research Board (HRB) is the lead agency in Ireland responsible for supporting and funding health research, information and evidence. We are motivated and inspired by our vision; Healthy people through excellent research and applied knowledge (

Applications are open for 2024 now.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.